為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

    限制級
    您即將進入之新聞內容 需滿18歲 方可瀏覽。
    根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

    《TAIPEI TIMES》 US surgeons successfully test pig kidney transplant

    A surgical team at NYU Langone Health in New York City last month examines a pig kidney attached to the body of a brain-dead woman for any signs of rejection.
Photo: AP

    A surgical team at NYU Langone Health in New York City last month examines a pig kidney attached to the body of a brain-dead woman for any signs of rejection. Photo: AP

    2021/10/21 03:00

    / Reuters, NEW YORK

    For the first time, a pig kidney has been transplanted into a human without triggering immediate rejection by the recipient’s immune system, a potentially major advance that could eventually help alleviate a dire shortage of human organs for transplant.

    The procedure done at New York University (NYU) Langone Health in New York City involved use of a pig whose genes had been altered so that its tissues no longer contained a molecule known to trigger almost immediate rejection.

    The recipient was a brain-dead patient with signs of kidney dysfunction whose family consented to the experiment before she was due to be taken off of life support, researchers said.

    For three days, the new kidney was attached to her blood vessels and maintained outside her body, giving researchers the chance to examine it.

    Test results of the transplanted kidney’s function “looked pretty normal,” said transplant surgeon Robert Montgomery, who led the study.

    The kidney made “the amount of urine that you would expect” from a transplanted human kidney, and there was no evidence of the vigorous, early rejection seen when unmodified pig kidneys are transplanted into non-human primates, he said.

    The recipient’s abnormal creatinine level — an indicator of poor kidney function — returned to normal after the transplant, Montgomery said.

    In the US, nearly 107,000 people are presently waiting for organ transplants, including more than 90,000 awaiting a kidney, the United Network for Organ Sharing said.

    Wait times for a kidney average three to five years.

    Researchers have been working for decades on the possibility of using animal organs for transplants, but have been stymied over how to prevent immediate rejection by the human body.

    Montgomery’s team theorized that knocking out the pig gene for a carbohydrate that triggers rejection — a sugar molecule, or glycan, called alpha-gal — would prevent the problem.

    The genetically altered pig, dubbed GalSafe, was developed by United Therapeutics Corp’s Revivicor unit. It was approved by the US Food and Drug Administration (FDA) in December last year, for use as food for people with a meat allergy and as a potential source of human therapeutics.

    Medical products developed from the pigs would still require specific FDA approval before being used in humans, the agency said.

    Other researchers are mulling whether GalSafe pigs could be sources of everything from heart valves to skin grafts for human patients.

    The NYU kidney transplant should pave the way for trials in patients with end-stage kidney failure, possibly in the next year or two, said Montgomery, himself a heart transplant recipient.

    Those trials might test the approach as a short-term solution for critically ill patients until a human kidney becomes available, or as a permanent graft.

    新聞來源:TAIPEI TIMES

    不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

    焦點今日熱門

    網友回應

    此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。